Massimo Crespi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Massimo Crespi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
D. Lisi
2 shared publicationsV Stigliano
2 shared publicationsAbbolito
1 shared publication- Alessandra Marinelli
Department of Experimental Medicine, Second University of Naples (SUN), 80138 Naples, Italy
1 shared publication - Alessandro Distante
Euro Mediterranean Scientific Biomedical Institute (ISBEM), 72023 Mesagne, Italy
1 shared publication - Alfredo Fucito
Sbarro Health Research Organization, Philadelphia, USA
1 shared publication
Latest Publications
- Open Access
- 19 June 2009
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 28 (1) , 86
Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005
Objectives: We aimed to determine the incidence of women's breast cancer in Italy without using statistical approximations. Methods: We analyzed the national hospitalizations database at the Ministry of Health to calculate the number of major surgeries in Italian women (mastectomies and quadrantectomies) due to breast cancer between 2000 and 2005, overall and by age groups (<44, 45–64, 65–74 and ≥ 75 years old). Results: Over the six years examined, an overall number of 100,745 mastectomies and 168,147 quadrantectomies were performed. A total of 41,608 major surgeries due to breast cancer were performed in the year 2000 and this number rose to 47,200 in 2005, with a 13.4% increase over six years. Conclusion: by analyzing the hospitalizations database concerning major breast surgery, incidence of breast cancer in Italy was found to be 26.5% higher than the official estimations which have been computed using statistical models (namely 47,200 vs. 37,300 cases in year 2005).
- 19 June 2009
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 28 (1) , 86
Open AccessIncidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005
Objectives: We aimed to determine the incidence of women's breast cancer in Italy without using statistical approximations. Methods: We analyzed the national hospitalizations database at the Ministry of Health to calculate the number of major surgeries in Italian women (mastectomies and quadrantectomies) due to breast cancer between 2000 and 2005, overall and by age groups (<44, 45–64, 65–74 and ≥ 75 years old). Results: Over the six years examined, an overall number of 100,745 mastectomies and 168,147 quadrantectomies were performed. A total of 41,608 major surgeries due to breast cancer were performed in the year 2000 and this number rose to 47,200 in 2005, with a 13.4% increase over six years. Conclusion: by analyzing the hospitalizations database concerning major breast surgery, incidence of breast cancer in Italy was found to be 26.5% higher than the official estimations which have been computed using statistical models (namely 47,200 vs. 37,300 cases in year 2005).
- 26 March 2008
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 46 (S 1) , 11-14
Colon Cancer in the EU: A Major Health Priority - Epidemiology
One of the EU missions in the domain of health is to correct inequalities in the delivery of care. In the more specific area of cancer prevention, screening and treatment, the available data show great inequalities in terms of incidence, mortality and survival rates related to Colorectal Cancer. In fact, the global burden of colorectal cancer (CRC) highlights this neoplasia as the second cause of cancer mortality in Europe with 74 750 deaths in males and 70 326 in females in the year 2002, nearly one third of the total worldwide mortality for CRC (528 978).
- 26 March 2008
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 46 (S 1) , 11-14
Colon Cancer in the EU: A Major Health Priority - Epidemiology
One of the EU missions in the domain of health is to correct inequalities in the delivery of care. In the more specific area of cancer prevention, screening and treatment, the available data show great inequalities in terms of incidence, mortality and survival rates related to Colorectal Cancer. In fact, the global burden of colorectal cancer (CRC) highlights this neoplasia as the second cause of cancer mortality in Europe with 74 750 deaths in males and 70 326 in females in the year 2002, nearly one third of the total worldwide mortality for CRC (528 978).
- 30 January 2002
- Vol. 48 (42) , 1635-40
Current trends in screening and secondary prevention of colorectal cancer.
Colorectal cancer is one of the most frequent neoplasms in Western countries with an estimated 400,000 deaths per year worldwide. Several randomized studies have demonstrated that screening programs with FOBT (Fecal Occult Blood Test) reduce mortality from 18 to 33%, whereas case-control and cohort studies with endoscopy have shown a mortality reduction ranging from 60 to 76%. The target population for secondary prevention is men and women aged more than 50 years and younger subjects in case first-degree relatives are affected or the family pedigree raises the suspicion of a genetic syndrome. This report summarizes the results of different screening strategies for average risk patients (FOBT, anamnestic risk questionnaire, sigmoidoscopy, colonoscopy and virtual colonoscopy) and the surveillance protocols applicable to high-risk patients, particularly for hereditary syndromes such as HNPCC and FAP.
- 30 January 2002
- Vol. 48 (42) , 1635-40
Current trends in screening and secondary prevention of colorectal cancer.
Colorectal cancer is one of the most frequent neoplasms in Western countries with an estimated 400,000 deaths per year worldwide. Several randomized studies have demonstrated that screening programs with FOBT (Fecal Occult Blood Test) reduce mortality from 18 to 33%, whereas case-control and cohort studies with endoscopy have shown a mortality reduction ranging from 60 to 76%. The target population for secondary prevention is men and women aged more than 50 years and younger subjects in case first-degree relatives are affected or the family pedigree raises the suspicion of a genetic syndrome. This report summarizes the results of different screening strategies for average risk patients (FOBT, anamnestic risk questionnaire, sigmoidoscopy, colonoscopy and virtual colonoscopy) and the surveillance protocols applicable to high-risk patients, particularly for hereditary syndromes such as HNPCC and FAP.
- Open Access
- 19 January 2002
- Published by Elsevier in Annals of Oncology
- Vol. 13 (1) , 47-50
Is colorectal cancer screening by fecal occult blood feasible?
Received 9 August 2001; accepted 10 October 2001.
- 19 January 2002
- Published by Elsevier in Annals of Oncology
- Vol. 13 (1) , 47-50
Open AccessIs colorectal cancer screening by fecal occult blood feasible?
Received 9 August 2001; accepted 10 October 2001.
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A50
Evaluation of Helicobacter pylori infection and CagA expression in an area with a low frequency of gastric cancer
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A50
Evaluation of Helicobacter pylori infection and CagA expression in an area with a low frequency of gastric cancer